menu search

It's time that altria unleashes its $11 billion ace in the hole

Altria's stake in Anheuser-Busch InBev is worth more than $11 billion. Selling the stake could unlock capital to dramatically reduce the dividend payo...

July 20, 2023, 6:00 am

Why shares of immunitybio were up on wednesday

ImmunityBio is a clinical-stage biotech company. The company's lead therapy candidate is Anktiva....

July 19, 2023, 12:57 pm

Disney ceo bob iger in ‘damage control' mode over possible sale of abc, espn

According to a source with knowledge Iger met with senior leaders of Disney's TV properties on Tuesday in order to do some "damage control," days afte...

July 19, 2023, 12:45 pm

Robert f. kennedy jr vows to back us dollar with bitcoin if elected president

Democratic presidential candidate Robert F. Kennedy Jr says he will back the U.S. dollar with Bitcoin i...

July 19, 2023, 6:59 am

Global indemnity group: upside still available, potential candidate for acquisition or merger

Global Indemnity Group has revealed that there is active interest from multiple parties in acquiring some or all of its business, causing a sharp rise...

July 19, 2023, 12:16 am

Valneva: vla1553 takes the lead in the chikungunya vaccine race

Positive Phase 3 data from Bavarian Nordic's chikungunya virus (CHIKV) vaccine candidate, PXVX0317, rei...

July 18, 2023, 4:17 am

Ipo update: turnstone biologics readies $75 million ipo plan

Turnstone Biologics Corp. has filed proposed terms for a $75.4 million IPO. The firm is developing drug treatment ...

July 17, 2023, 3:06 pm

Bridgebio pharma stock soars on heart disease drug study results

BridgeBio Pharma Inc shares surged 69% to $30.78 in late-morning trading on Monday after the commercial-stage biopharmaceutical company announced that...

July 17, 2023, 11:33 am

Cvs, phillips 66 and lear look good on this gauge

A good tool for spotting turnaround candidates is the price-sales ratio....

July 17, 2023, 10:41 am

Biovie's clinical dementia drug ne3107 shown to reduce dna methylation

BioVie Inc (NASDAQ:BIVI) presented a poster over the weekend showcasing the epigenetic basis for how its drug ...

July 17, 2023, 9:09 am

2 nasdaq stocks that could soar this week

BridgeBio Pharma is slated to announce late-stage results for an important pipeline candidate on Monday...

July 16, 2023, 8:00 pm

Savara: a speculative play

Today, we circle back on a small development firm called Savara for the first time in over two years. Its primary drug ...

July 16, 2023, 11:50 am

Why eli lilly stock is rising today

Eli Lilly has agreed to buy privately owned Versanis Bio in a deal that could be worth up to $1.93 billion. Through this deal, Lilly will gain a novel...

July 14, 2023, 12:43 pm

Roivant (roiv) up on reports of colitis drug sale to roche

Shares of Roivant ROIV rose almost 12% on Thursday after a Wall Street Journal (WSJ) article reported that Roche RHHBY was close to buying ROIV's infl...

July 14, 2023, 12:39 pm

Zyversa therapeutics’ ceo, stephen c. glover, is an invited speaker at h.c. wainwright 2nd annual kidney conference to be held virtually on july 25, 2023

ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two prop...

July 14, 2023, 11:37 am

Acadia (acad) expands existing licensing deal with neuren

Acadia (ACAD) rises 23% for extending its existing licensing agreement with Neuren to include ex-North American rights to trofinetide along with the g...

July 14, 2023, 9:39 am

Deep value conagra brands pulls into the buy zone

Conagra Brands NASDAQ: CAG isn't leading the consumer staples sector but is a leading candidate for new...

July 14, 2023, 7:12 am

Roivant in talks to sell stomach drug to roche in deal valued at more than $7 billion

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days...

July 13, 2023, 5:50 pm

Okta: buy the dip

Cloud security firm Okta has seen a decline in customer growth, which it attributes to the macro environment, but competition may also be a factor. De...

July 12, 2023, 3:45 am

Root: the carvana short squeeze sympathy play

Carvana Co. has seen a 600% increase in 2023 due to improving financial performance and growth in the electric vehicle market. Carvana's success is ex...

July 12, 2023, 2:28 am


Search within

Pages Search Results: